BioUK Life Science Registry

Member list of BioUK

Below you find a list of all members of BioUK in alphabetical order.
Results 241 - 260 out of 523 displayed
Ipsen R&D United Kingdom

37 North Wharf Road
5th Floor The Point
London, W2 1AF
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Proteins

Indications:

Neoplasms / cancer / oncology, Endocrine, nutritional and metabolic diseases / endocrinology, Diseases of the nervous system / neurology

Employees:
Worldwide: 5300
Description:

Ipsen R&D is a pioneering research and development organization with experience in recombinant botulinum toxin technology. The botulinum toxin platform has very broad therapeutic potential in many areas: neuroscience as well as oncology, endocrinology, and regenerative medicine.

Isogenix Limited

Roosevelt Drive
Bioescalator Innovation Building
Oxford, OX3 7FZ
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Other, Gene therapy, Nucleic acid drugs, Proteins

Indications:

Diseases of the nervous system / neurology, Musculoskeletal system and connective tissue / Orthopedics

Employees:
At this location: 10
Worldwide: 10
Description:

Isogenix Limited is engaged in developing precision medicines by harnessing the properties of protein isoforms. Using a proprietary approach, the aim is to identify and develop precision therapies, with an initial focus on neuromuscular and neurological diseases. Combining cutting-edge research and technologies, Isogenix is committed in developing treatments that restore function and improve patient outcomes in these challenging disease areas.

IsomAb Ltd

Pennyfoot Street
Biocity Nottingham, Innovation Building
Nottingham, NG1 1GF
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Antibodies

Indications:

Neoplasms / cancer / oncology, Endocrine, nutritional and metabolic diseases / endocrinology, Cardiovascular / cardiology, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Products:
In development: 2
Employees:
Worldwide: 6
Description:

IsomAb Ltd is a biotechnology company developing isoform-specific disease modifying antibody treatments for serious and life-threatening diseases. The company's is developing its first antibody therapeutic ISM-001, which is a high affinity, neutralising antibody that specifically binds VEGF165b.

Jack Fertility Ltd

Quarry Rd
​ Wood Centre for Innovation
Oxford, OX3 8SB
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Analytical services, Diagnostic instrumentation, Diagnostic services

Indications:

Genitourinary system / Urology

Description:

Jack Fertility Ltd are engaged in developing a semen home collection kit. The kit offers a lab-grade semen analysis results without going in a clinic, to help men and people with sperm better understand and improve their fertility, discreetly, from home.

James Cowper LLP

201 Cumnor Hill
Cumnor
Oxford, OX2 9PJ
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Business development, Financial services

Description:

James Cowper is a firm of accountants and business advisors in Oxford, helping businesses and individuals in Oxford and the wider Oxfordshire region to maximise their potential. They provide a wide range of financial services, including Accounts and Business Advisory, Audit and Assurance, Business Tax, Corporate Finance, Global Mobility Tax, Indirect Tax Services, International Advisory, Outsourcing, Payroll, Private Client Services, and Turnaround, Restructuring & Insolvency.

Jellagen Ltd

Parkway
Unit G6, Capital Business Park, St Mellons
Cardiff, CF3 2PY
United Kingdom

Main sector:

Medical Technology

Subsector:

Biomaterials, Regenerative Medicine, Wound care

Products:
On the market: 1
Description:

Jellagen is a biotech company developing a proprietary next-generation biomaterial, Collagen Type 0. The company's JellaGel™ is a Next Generation Collagen Type 0 Hydrogel for in vitro cell culture and tissue engineering, offering customers a natural, non-mammalian alternative to mammalian and synthetic hydrogels that are currently on the market. Jellagen's strategic mission is to utilise sustainable marine species and natural resources in order to develop technical and scientific high-value research and medical device products, meeting state-of-the-art specifications.

Johnson & Johnson

1 Johnson And Johnson Plaza
New Brunswick, 08933
USA

Main sector:

Pharma (fully integrated)

Subsector:

Antibodies, Anti-infectives, Biosimilars, Peptides, Small molecule therapeutics, Vaccines, Molecular diagnostics, Immunotherapy

Indications:

Infectious and parasitic diseases / infectiology / parasitology, Neoplasms / cancer / oncology, Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology, Endocrine, nutritional and metabolic diseases / endocrinology, Mental and behavioural disorders / psychiatry /psychology, Diseases of the nervous system / neurology, Diseases of the eye / ophthalmology, Cardiovascular / cardiology, Respiratory / pulmonology, Digestive system / gastroenterology, Skin and subcutaneous tissue / dermatology, Musculoskeletal system and connective tissue / Orthopedics, Genitourinary system / Urology, Congenital malformations, deformations and chromosomal abnormalities / medical genetics, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified, Injury, poisoning and certain other consequences of external causes / toxicology

Employees:
Worldwide: 138200
Description:

Johnson & Johnson, commonly known as J&J, is a global healthcare company headquartered in New Brunswick. The company focuses on developing and manufacturing pharmaceuticals, medical technologies, and healthcare solutions. Its operations are organized into two main business segments: Innovative Medicine and MedTech. The company develops treatments and products across areas such as oncology, immunology, neuroscience, cardiovascular disease, surgery, orthopaedics, and vision care. J&J operates in more than 60 countries and serves healthcare markets worldwide through research, manufacturing, and distribution networks.

Johnson & Johnson Innovation

One Chapel Place
London, W1G0BG
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Business development, Financial services

Indications:

Endocrine, nutritional and metabolic diseases / endocrinology, Mental and behavioural disorders / psychiatry /psychology, Diseases of the nervous system / neurology, Diseases of the eye / ophthalmology, Cardiovascular / cardiology

Description:

Johnson & Johnson Innovation is a science and business center to collaborate with innovators to incorporate science into healthcare solutions, including medical device, consumer healthcare products, and pharmaceuticals. The company is focused on the advancement of new healthcare solutions in the consumer, pharmaceutical, and medical devices sectors. The company provides financing tools that include early-stage research funding, seed funding, equity investments, licensing, and collaborations. Additionally, the company also offers partners access to international markets, pricing and reimbursement, market testing, company creation services, etc.

Kadans Science Partner

20 Water Street
London Innovation Centre
London, E14 5GX
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Science / Technology park, Research facility

Description:

Kadans Science Partner UK develops, owns, and manages laboratory, office, and research facilities within science and innovation clusters across the United Kingdom. The firm provides specialized real estate and workplace environments for organizations in the life sciences, health, high technology, and related research sectors. The company supports collaboration by offering facilities and services within established science campuses and innovation ecosystems.

KalVista Pharmaceuticals, Ltd.

Bybrook Rd
Porton Science Park,Wiltshire
Porton Down, SP4 0BF
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Small molecules

Indications:

Diseases of the eye / ophthalmology, Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Employees:
At this location: 58
Worldwide: 275
Description:

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small-molecule protease inhibitors for diseases with significant unmet needs. The company is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved target enrollment for the phase 3 CONFIDENT clinical trial. In addition, KalVista’s oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve the treatment for people living with HAE and other diseases.

Kathryn Simpson Consulting Limited

9 Arkenside Mews
Cirencester, GL7 1QQ
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Management consulting

Description:

Kathryn Simpson Consulting specializes in strategic change consulting to knowledge-based (e.g. pharma, consumer, life sciences) organisations in the UK, Europe and Canada. Services include facilitating and developing strategic plans, scoping strategic initiatives, and coaching leaders to create and achieve their shared vision through flawless execution.

Kelp Industries Ltd

Midland Road
Science Creates Old Market
Bristol, BS2 0NS
United Kingdom

Main sector:

Biotechnology - Other

Subsector:

Industrial Biotechnology

Description:

Kelpi is a company that develops seaweed-based barrier coatings for the packaging industry to replace fossil-fuel plastics in the packaging industry. The company creates food-safe, carbohydrate-based formulations that are combined with vegetable oils to produce ultra-thin (approximately 0.01mm) barrier coatings.

Kent Science Park

Broadoak Road
Sittingbourne, ME9 8AG
United Kingdom

Main sector:

Public / Non-Profit Organizations / Medical Facilities

Subsector:

Science / Technology park

Description:

Kent Science Park is home to 42 buildings of agritech, biotech, biopharma and nutraceutical companies. Located less than an hour from London St Pancras, the site is a well-connected base for growing companies.

Managed by Pioneer Group, it acts as an incubator, supporting companies through Accelerator, Start-up and Launch programmes and connecting founders with expert mentors and growth opportunities.

Kindling Bio

Innovation Gateway, The London Cancer Hub, Cotswold Road, Sutton
London, SM2 5NG
United Kingdom

Main sector:

Biotechnology - Therapeutics and Diagnostics

Subsector:

Gene therapy

Indications:

Neoplasms / cancer / oncology

Employees:
At this location: 2
Worldwide: 2
Description:

Kindling Bio is a UK-based biotech company developing gene therapies specifically for childhood cancers, using a scalable platform that helps the immune system recognise and destroy paediatric tumours while reducing long-term treatment toxicity.

Kinomica Ltd

Alderley Park, Alderley Edge, Room 1S77
Macclesfield, SK10 4TG
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Other, Bioinformatics, Proteomics

Description:

Kinomica is a company that specializes in cell signalling and develops diagnostic tools to help doctors make informed treatment decisions. Company platform, KScan, uses advanced bioinformatics and phosphoproteomics to analyze cell signals and identify the best treatment options for individual patients. By providing a deeper understanding of disease mechanisms and drug responses, company's aim to improve patient outcomes and enable more effective treatment strategies.

Kriston Technology Limited

2 Lodge Road
Hanborough Business Park
Long Hanborough, OX29 8LH
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

IT services

Description:

Kriston Technology provides IT support in Oxford and Oxfordshire areas for life sciences, STEM, pharmaceutical, biotechnology, and other industries. They provide fully tailored IT solutions for pharmaceutical and biotechnology companies.
Kriston Technology caters to those businesses that cannot afford to have dedicated IT staff, and are looking for a trusted partner and advisor to manage their IT support.

Kāhu SiliconBio

Roslin Innovation Centre, Charnock Bradley Building, Easterbush Campus
Midlothian, EH25 9RG
United Kingdom

Main sector:

Biotechnology - R&D Services

Subsector:

Biochips, Bioelectronics

Description:

Kāhu SiliconBio is a biotechnology company that specializes in developing advanced liquid chemical sensing solutions by creating "biohybrid" electronic devices that interface living microorganisms with silicon chips. The company leverages the natural evolutionary ability of microbes to detect trace chemicals in liquids with extreme sensitivity and speed.

Lab Thread Ltd.

MEPC Silverstone Park Innovation Centre, Silverstone Park, Silverstone
Towcester, NN12 8GX
United Kingdom

Main sector:

Supplier & Engineering

Subsector:

Distributors, Software

Description:

Lab Thread Ltd. is the software platform company which connects the research projects, lab operations, and scientific data. The company simplifies the scientific projects, molecular biology research with the company's software platform.

Lehane Consulting Ltd.

Room 73, The Mansion House, Wrest Park. Silsoe
Bedford, MK45 4HR
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Management consulting, Sales & Marketing

Description:

Lehane Consulting Ltd offers unparalleled medical diagnostic knowledge to companies developing diagnostic tools that enhance and innovate healthcare. The company helps customers to navigate the global market taking their diagnostic products from initial concept to successful launch and beyond.

Leyton UK

77-85 Fulham Palace Road
Horatio House
London, W6 8JB
United Kingdom

Main sector:

Professional Services and Consulting

Subsector:

Financial services

Description:

Leyton is a consulting firm with a goal to improve the financial performance and profitability of its clients without impacting their core business. In the UK, specific expertise is in the optimization of research and development (R&D) tax relief and credits, R&D grant funding, the patent box regime, and LLP structures.

Results 241 - 260 out of 523 displayed